A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer
Clinical trial NCT01364493 · COMPLETED
Trial details
- NCT number
- NCT01364493
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-08-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.